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We detected WU polyomavirus (WUPyV) in a bronchoal-
veolar lavage sample from lungs transplanted into a recipi-
ent with Job syndrome by using immunoassays specific for 
the WUPyV viral protein 1. Co-staining for an epithelial cell 
marker identified most WUPyV viral protein 1–positive cells 
as respiratory epithelial cells.
WU polyomavirus (WUPyV) was discovered in a child with pneumonia in 2007 (1). Subsequent 
studies showed that WUPyV infection is common (2–4), 
and viral DNA can be detected in a variety of specimen 
types, including respiratory tract secretions (5). Howev-
er, the virus has yet to be associated with any disease, 
and the specific cell type(s) infected by WUPyV has not 
been identified. Other human polyomaviruses are known 
pathogens, which typically cause disease in the context of 
immunosuppression (6–8).
Job syndrome is an immune disorder characterized 
by eczematoid dermatitis, recurrent skin and pulmonary 
infections, increased levels of IgE, and impaired T and 
B cell memory (9). This disorder is caused by dominant-
negative mutations in the STAT3 gene (9). We report 
WUPyV cell tropism in lungs transplanted into a recipient 
with Job syndrome.
The Study
These studies were approved by institutional review boards 
at the National Institutes of Health (NIH) and Washington 
University. A 28-year-old woman with Job syndrome was 
seen at the NIH Clinical Center 6 months after bilateral lung 
transplantation. She had a bronchoscopic evaluation to follow 
up on endobronchial aspergillosis. Pathologic examination 
of a bronchoalveolar lavage (BAL) sample showed scattered 
cells, primarily columnar bronchial cells, with cytomorpho-
logic changes reminiscent of BK polyomavirus (BKPyV)–
infected decoy cells. The cells stained positive with PAb416, 
a monoclonal antibody against the SV40 large T antigen. 
The patient had BKPyV viremia (8.1 × 105 copies/mL) and 
viruria (6.9 × 109 copies/mL). JC polyomavirus was also de-
tected in the urine but not in the blood. The BAL sample was 
weakly positive for BKPyV by PCR (<250 copies/mL) and 
negative for JC polyomavirus. Clinical or radiographic signs 
and symptoms of infection were not apparent.
Nonenveloped virions were purified from the BAL sam-
ple by using ultracentrifugation with Optiprep (#D1556; Sig-
ma-Aldrich, St. Louis, MO, USA) (10). DNA was extracted 
from the virion preparation and subjected to random-primed 
rolling circle amplification (RCA) and restriction enzyme 
digestion, which yielded 2 strong bands. The bands were 
cloned and identified as WUPyV by using Sanger sequenc-
ing. The complete genomic sequence of the isolate, desig-
nated J1 (GenBank accession no. KJ643309), was confirmed 
by using miSeq analysis (Illumnina, San Diego, CA, USA) 
of the RCA product. A second WUPyV variant with 2-nt 
polymorphisms and a single base insertion was also detected 
in the RCA product. No other known viruses (including BK-
PyV) were observed by deep sequencing.
We developed an immunohistochemical (IHC) assay 
to detect the WUPyV viral protein 1 (WU-VP1) by using 
an IgG2b designated NN-Ab06. Recombinant histidine-
tagged WU-VP1 protein was generated by expressing WU-
VP1 (GenBank accession no. ABQ09289) in Escherichia 
coli from a Gateway pDEST17 plasmid (Life Technologies, 
Carlsbad, CA, USA) and purifying the protein by using an 
affinity Ni-NTA column (Pierce Biotechnology, Rockford, 
IL, USA). After generation of hybridomas, we identified 
clones producing antibody against WU-VP1 by ELISA and 
immunoblot. Clones that cross-reacted with KI polyomavi-
rus VP1 (KI-VP1) were identified by ELISA with glutathi-
one S-transferase–tagged KI-VP1 (2) and eliminated.
To generate positive control cells for IHC assay optimi-
zation, we transfected 293T cells with plasmid pDEST26-
WU-VP1 (Life Technologies). A subset of cells was fixed 
in 10% neutral-buffered formalin and embedded in paraffin. 
IHC testing was performed by deparaffinizing slides in xy-
lene and rehydrating them in a series of ethanol solutions. 
After treating slides with 3% hydrogen peroxide, antigen 
was retrieved in citrate buffer, pH 6.0 (10 mmol/L citric 
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acid, 0.05% Tween 20) in a pressure cooker (PC6–25; Ne-
sco, Two Rivers, WI, USA) for 3 min on the high setting.
Slides were blocked in 1.5% normal horse serum (#S-
200; Vector Laboratories, Burlingame, CA, USA) and in-
cubated with NN-Ab06, then with biotinylated anti-mouse 
IgG (BA-2000; Vector Laboratories). After development 
by using the Vectastain Avidin–Biotin Complex Kit (#PK-
6100; Vector Laboratories) and (3,3′-diaminobenzidine) 
(#SK-4100; Vector Laboratories), we counterstained tis-
sues with hematoxylin.
Cells with prominent dark staining were seen (Figure 
1, panel A). A serial section of the same cell block stained 
with an isotype-matched antibody (#557351, mouse IgG2b: 
BD Biosciences, San Jose, CA, USA) (Figure 1, panel B) 
and mock transfected cells stained with NN-Ab06 (Figure 
1, panel C) showed negative results. Western blotting was 
performed as an independent means of evaluating specific-
ity of NN-Ab06 (11). NN-Ab06 reacted with WU-VP1 pro-
tein lysate but not with KI-VP1 lysate, which is the most 
closely related virus to WUPyV. KI-VP1 has 65% amino 
acid identity with WU-VP1.
We applied the WU-VP1 IHC assay to formalin-fixed, 
paraffin-embedded sections of the BAL sample. Prominent 
dark staining of cells with enlarged nuclei and a ground 
glass appearance characteristic of viral cytopathic changes 
were observed (Figure 1, panel D). Staining was not seen 
in serial sections stained with the isotype antibody (Figure 
1, panel E) or with no antibodies.
Many WUPyV-positive cells were cuboidal to co-
lumnar and showed other morphologic features consistent 
with respiratory epithelial cells. To determine their etiol-
ogy, we developed a double immunofluorescence (dIF) 
assay with a polyclonal antibody against WU-VP1 (2), 
designated NN-Ab01, and a monoclonal antibody against 
cytokeratins (#M3515; Dako, Carpinteria, CA, USA). De-
paraffinization and antigen retrieval were accomplished as 
noted above, and sections were blocked in Superblock T20 
(#37516; Thermo Scientific, Waltham, MA, USA). To vali-
date the assay, we performed immunofluorescence analysis 
with NN-Ab01 on positive control 293T cells expressing 
WU-VP1. The nucleus was counterstained with Hoechst 
(#H21491; Life Technologies). Several WU-VP1-positive 
Figure 1. WU polyomavirus antigen in bronchoalveolar lavage specimens from lungs transplanted into a recipient (28-year-old woman) with 
Job syndrome. Immunohistochemical analysis of 293T cells transfected with pDEST26-WU–virus protein 1 and stained as follows. A) WU virus 
protein 1 monoclonal antibody (NN-Ab06). B) Isotype control. C) Mock transfected 293T cells stained with NN-Ab06. D) Bronchoalveolar lavage 
specimen stained with NN-Ab06 showing prominent dark staining of cells with enlarged nuclei and a ground glass appearance characteristic of 
viral cytopathic changes (arrows). E) Isotype control. Original magnifications ×400 in panels A–C and ×600 in panels D and E.
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cells were observed (Figure 2, panel A); a serial section 
stained with preimmune serum at the same dilution showed 
a negative result (Figure 2, panel B).
For dIF, BAL sections were incubated first with the 
primary antibodies and then with fluorescently labeled sec-
ondary antibodies (#A10042 anti-rabbit-568 and #A10042 
anti-mouse-488; Life Technologies). We observed cells 
positive for WU-VP1 and cytokeratin (Figure 2, panels C, 
D), which identified these cells as epithelial cells. Of the 
136 WU-VP1-positive cells, 77 (57%) were also cytoker-
atin positive. A serial section of the BAL sample stained 
with an isotype-matched antibody to the cytokeratin anti-
body (#555746 mouse IgG1; BD Biosciences) and preim-
mune rabbit serum was negative.
We hypothesized that the remaining 43% of WU-
VP1-positive, cytokeratin-negative cells might be mac-
rophages. However, a dIF assay using NN-Ab01 and an 
antibody against CD68 (#M0814; Dako), a macrophage 
marker, showed WU-VP1 and CD68 single-positive cells 
but no double-positive cells. In addition, a stain with 
NN-Ab01 and an antibody against CD45 (#M351529–2; 
Dako), a marker for hematopoietic cells, also showed 
negative results.
Conclusions
Before this study, to our knowledge, no specific cell type 
had been identified as susceptible to WUPyV infection. We 
found that WUPyV antigen was detected in human respira-
tory epithelial cells. The presence of nuclease-resistant vi-
ral DNA from the Optiprep gradient and detection of WU-
VP1, which is believed to be expressed concomitantly with 
DNA replication (12), suggests that the cells were infected 
by WUPyV and that the WUPyV life cycle reached at least 
the stage of late gene expression. The clinical role of in-
fection by WUPyV is uncertain, given that the patient was 
not experiencing any recognizable symptoms. Although 
we attempted to identify a second population of WU-VP1-
positive, cytokeratin-negative cells, the etiologic features 
of these cells remains uncertain.
Our patient had Job syndrome, a primary immunodefi-
ciency not previously associated with polyomavirus suscep-
tibility. It is possible that immunosuppressant medications, 
Figure 2. WU polyomavirus 
antigen in respiratory epithelial 
cells from lungs transplanted 
into a recipient (28-year-old 
woman) with Job syndrome. 
Immunofluorescence of 293T 
cells transfected with pDEST26-
WU–virus protein 1 and stained 
with A) WU virus protein 1 
polyclonal antibody (NN-Ab01) 
or B) preimmune serum. C) 
Double immunofluorescence 
with NN-Ab01 (red) and a 
monoclonal antibody against 
cytokeratin (green) showing 
a double-positive cell from 
the bronchoalveolar lavage 
specimen. D) Bronchoalveolar 
lavage specimen with multiple 
WU virus protein 1/cytokeratin 
double-positive cells. Original 
magnifications ×100 in panels 
A and B, ×600 in panel C, and 
×400 in panel D.
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which include prednisone and tacrolimus, altered suscepti-
bility to virus infection. Other human polyomaviruses are 
believed to exclusively cause disease in immunocompro-
mised hosts. This case suggests that immunosuppression 
might also play a role in WUPyV infection and expands our 
understanding of WUPyV biology.    
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